Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain ENZ message board posts where the ticker symbol ENZ has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest ENZ SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000930413-18-003233 Size: 4 KB
2018-10-31
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000930413-18-003136 Size: 6 KB
2018-10-22
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000930413-18-003129 Size: 4 KB
2018-10-22
10-K  Documents   Interactive Data Annual report [Section 13 and 15(d), not S-K Item 405]
Acc-no: 0000930413-18-003072 (34 Act)  Size: 7 MB
2018-10-15 001-09974
181123113
8-K  Documents Current report, items 2.02, 7.01, and 9.01
Acc-no: 0000930413-18-003069 (34 Act)  Size: 116 KB
2018-10-15 001-09974
181122519
8-K  Documents Current report, items 8.01 and 9.01
Acc-no: 0000930413-18-002726 (34 Act)  Size: 32 KB
2018-08-27 001-09974
181039038
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000930413-18-002644 Size: 6 KB
2018-08-20
S-8  Documents Securities to be offered to employees in employee benefit plans
Acc-no: 0000930413-18-002548 (33 Act)  Size: 194 KB
2018-08-13 333-226799
181009928
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000930413-18-002502 Size: 5 KB
2018-08-02
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000930413-18-002501 Size: 5 KB
2018-08-02
More ENZ SEC Filings


Related news from
Mon, 29 Oct 2018
12:25:00 +0000
Market Trends Toward New Normal in Polaris Industries, NIKE, Charles River Laboratories International, Actuant, Caesarstone, and Enzo Biochem — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Oct. 29, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Wed, 17 Oct 2018
12:15:53 +0000
The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 16) Endo International PLC (NASDAQ: ENDP ) Krystal Biotech ...
Wed, 17 Oct 2018
01:42:52 +0000
Edited Transcript of ENZ earnings conference call or presentation 16-Oct-18 12:30pm GMT
Q4 2018 Enzo Biochem Inc Earnings Call
Tue, 16 Oct 2018
12:52:07 +0000
The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 15) BioDelivery Sciences International, Inc. (NASDAQ: BDSI ...
Tue, 16 Oct 2018
10:30:00 +0000
Enzo Biochem, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / October 16, 2018 / Enzo Biochem, Inc. (NYSE: ENZ ) will be discussing their earnings results in their 2018 FourthQuarter Earnings to be held on October16, 2018 at 8:30 AM Eastern ...
Mon, 15 Oct 2018
20:20:31 +0000
Enzo Biochem: Fiscal 4Q Earnings Snapshot
NEW YORK (AP) _ Enzo Biochem Inc. (ENZ) on Monday reported a fiscal fourth-quarter loss of $5.8 million, after reporting a profit in the same period a year earlier. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research.
Mon, 15 Oct 2018
20:05:00 +0000
Enzo Biochem Reports Fourth Quarter and Fiscal 2018 Results
Molecular Assay Approvals from New York State Department of Health and Planned Acquisition of New Facility Highlight Progress Advancing Growth Strategy
Thu, 11 Oct 2018
16:49:00 +0000
Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal 2018 Results Tuesday, October 16, 2018 at 8:30 AM E.T.
To listen to the conference call dial 1-888-459-5609. International callers can dial 1-973-321-1024. A rebroadcast of the call will be available starting approximately two hours after the conference call ends, through 12 AM (E.T.) Tuesday October 30, 2018.
Wed, 03 Oct 2018
23:33:00 +0000
Top 5 Biotech Stocks for 2018
Many biotechnology products do not produce the desired results consistently, while others fail to gain acceptance in the marketplace. Given Celgene's solid long-term track record, the lackluster year-to-date performance may represent a buying opportunity.
Mon, 27 Aug 2018
12:30:00 +0000
Enzo Biochem to Acquire New Facility for Manufacturing and Distribution to Advance Its Diagnostic and Therapeutic Growth Strategy
Enzo Biochem, Inc. (ENZ), an integrated diagnostic and therapeutics company, announced today that, as part of implementing its growth strategy, it has entered into an agreement to purchase a commercial facility with nearly 36,000 square feet in Farmingdale, NY. The building is adjacent to the Company’s current Long Island campus and enhances the infrastructure needed to produce and distribute Enzo’s expanding low cost, diagnostic platform products and related services. The Company’s platform development includes automation-compatible reagent systems and associated products for sample collection and processing through analysis.
Wed, 18 Jul 2018
13:00:00 +0000
Enzo Biochem Reports Validation of Three High Quality, Low Cost Biomarkers for Detecting Cancers and Their Progression, Especially in Women’s Health Area
Enzo Biochem Inc. (ENZ) today announced the validation of three clinically relevant, cost-efficient biomarker detection tests for charting the progression of various cancers, especially in the field of women’s health. The validated tests complement Enzo’s POLYVIEW® immunohistochemistry (“IHC”) and in situ hybridization (“ISH”) detection platform, an enhanced diagnostic detection system used by pathologists in reading tissue biopsies and favorably cited by a leading peer review publication for showing no false positives.
Fri, 06 Jul 2018
11:10:00 +0000
Blog Exposure - Bruker Buys Dutch Milk Analysis Equipment Manufacturer Lactotronic to Expand its Presence in the Dairy Industry
LONDON, UK / ACCESSWIRE / July 6, 2018 / If you want access to our free research report on Bruker Corp. (NASDAQ: BRKR), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=BRKR as the Company's latest news hit the wire. On July 03, 2018, the Company announced that it has signed an agreement to acquire the entire business of Drachten, The Netherlands-based Lactotronic B.V. Lactotronic specializes in developing, manufacturing, and distributing milk analyzing equipment and instruments for the dairy industry. Active-Investors.com is currently working on the research report for Enzo Biochem, Inc. (NYSE: ENZ), which also belongs to the Healthcare sector as the Company Bruker.
Wed, 13 Jun 2018
10:03:00 +0000
Edited Transcript of ENZ earnings conference call or presentation 12-Jun-18 12:30pm GMT
Q3 2018 Enzo Biochem Inc Earnings Call
Tue, 12 Jun 2018
12:47:30 +0000
Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 11) ABIOMED, Inc. (NASDAQ: ABMD ) AngioDynamics, Inc. (NASDAQ: ...
Mon, 11 Jun 2018
20:10:00 +0000
Enzo Biochem Reports Third Quarter Results
Enzo Biochem Inc. , an integrated diagnostic company, today reported results for the third fiscal quarter and nine months ended April 30, 2018, in addition to noting significant progression of its strategic plan aimed at providing cost-effective, high performing and easily adaptable products and services to hospital and independent laboratories.
Wed, 06 Jun 2018
14:00:00 +0000
Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2018 Results Tuesday, June 12, 2018 at 8:30 AM E.T.
To listen to the conference call dial 1-888-459-5609. International callers can dial 1-973-321-1024. A rebroadcast of the call will be available starting approximately two hours after the conference call ends, through 12 AM (E.T.) Tuesday June 26, 2018.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum has been the most valuable tool I have ever come across when it comes to managing my investments. I can honestly say that the information shared on ValueForum has led me to retire earlier than expected. This is a wonderful investment site, period." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards